Dr Andrew Latchford is a Consultant Gastroenterologist at St Mark’s National Bowel Hospital, Director of the Polyposis Registry and Co-Director of the Centre for Familial Intestinal Cancer. He is also an Honorary Senior Lecturer at Imperial College, London. Dr Latchford’s main focus of research interest is on polyposis syndromes. He has extensive clinical experience with all polyposis syndromes and have co-authored national and international, adult and paediatric guidelines on polyposis syndromes and Lynch syndrome, and familial colorectal cancer. Dr Latchford was an expert advisor to NICE in the development of guidelines for universal tumour MMR testing and helped develop mainstreaming genetic testing pathways for Lynch syndrome at St Mark’s. He is an elected Council member for InSiGHT and have been involved in the development of ClinGen-InSiGHT gene specific ACMG/AMP variant classification criteria for polyposis genes.